Pfizer CEO Albert Bourla and dozens of other biotech and pharmaceutical company leaders have signed an open letter in support of the US Food and Drug Administration’s authority “to approve and regulate safe, effective medicines for every American” after Friday’s decision by a Texas district court judge to halt the agency’s approval of mifepristone, one of the medications used in abortion procedures.